DRUG DEVELOPMENT DECONSTRUCTOR MANIFESTO: : “Tell me how you read and I'll tell you who you are.” ― Martin Heidegger
Friday, July 13, 2012
AZ: A Rescue Plan?
AZ: Rescue plan?
From here.
AstraZeneca Plc (AZN) aims to advance at least eight medicines into late-stage tests within three years, one of its top research and development executives said today.
“We’ve set our R&D organization a goal of delivering eight to 11 Phase 3 projects,” Menelas N. Pangalos, executive vice president of the company’s Innovative Medicine Research Units, told reporters at a briefing in London
Well, the plans are very ambitious but clearly not realistical. Why AZ did not use the same plans earlier? And what have been changed in order to AZ could rely on these new plans in drug development and why these plans will be more successful than the previous ones? I would recommend to AZ to develop a plan B...
Thursday, July 12, 2012
A kind of colonization...
The scheme is universal - it works for other countries (Japan, Brasil, South Africa etc), not just for Russia
Sekatsky. Imagined...
The first part of four (the rest can be found on youtube). He should be more detailed regarding quantum aspects and the imagined area...
GSK corrupted doctors and academics. Now is clear for “Nature”!
Basically every(!) person who works in academia or R&D of pharma-companies knows that Big Pharma buys “patronizes” prominent academicians/researchers BUT it takes a noisy scandal in order this issues become sufficiently attractive for the big scientific media such as Nature:
According to the US complaint, GSK also lavished some doctors and academics with “sham consulting fees” and other payments, as well as gifts and attendance at luxury conferences in venues such as Bermuda and Jamaica — sometimes with sailing or deep-sea fishing thrown in — to encourage them to prescribe drugs for off-label uses (see go.nature.com/dbhkht). Speakers could earn $1,000–2,500 per hour to talk at promotional events, with some negotiating 'six packs' of $12,000-worth of talks over two days. One speaker earned about $1.5 million between 2001 and 2003. Nice work if you can get it — and too many could. Andrew Witty, chief executive of GSK, last week apologized for the company's past behaviour, but argued that since he took the helm in 2008, GSK has implemented deep reforms.
Well, the situation is pretty simple and it was easily deconstructed for a couple of months ago. After the scandal with GSK nothing will be changed... Unfortunately.
Wednesday, July 11, 2012
Quote of the day. Signs and symbols...
Конфуций
Subscribe to:
Posts (Atom)